DK0832101T3 - Urethan-formidlede, GST-specifikke molekylfrigörelsessystemer - Google Patents

Urethan-formidlede, GST-specifikke molekylfrigörelsessystemer

Info

Publication number
DK0832101T3
DK0832101T3 DK96918420T DK96918420T DK0832101T3 DK 0832101 T3 DK0832101 T3 DK 0832101T3 DK 96918420 T DK96918420 T DK 96918420T DK 96918420 T DK96918420 T DK 96918420T DK 0832101 T3 DK0832101 T3 DK 0832101T3
Authority
DK
Denmark
Prior art keywords
glu
gly
asp
formula
gst
Prior art date
Application number
DK96918420T
Other languages
Danish (da)
English (en)
Inventor
Lawrence M Kauvar
Matthew H Lyttle
Apparao Satyam
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Application granted granted Critical
Publication of DK0832101T3 publication Critical patent/DK0832101T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK96918420T 1995-06-07 1996-06-07 Urethan-formidlede, GST-specifikke molekylfrigörelsessystemer DK0832101T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/476,119 US5908919A (en) 1993-10-01 1995-06-07 Urethane mediated, GST specific molecular release systems
PCT/US1996/009831 WO1996040739A2 (fr) 1995-06-07 1996-06-07 Systemes de liberation moleculaire induits par l'urethane specifiques de la gst

Publications (1)

Publication Number Publication Date
DK0832101T3 true DK0832101T3 (da) 2004-11-29

Family

ID=23890586

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918420T DK0832101T3 (da) 1995-06-07 1996-06-07 Urethan-formidlede, GST-specifikke molekylfrigörelsessystemer

Country Status (10)

Country Link
US (1) US5908919A (fr)
EP (1) EP0832101B1 (fr)
JP (1) JPH11507370A (fr)
AT (1) ATE273318T1 (fr)
AU (1) AU722595B2 (fr)
CA (1) CA2224191A1 (fr)
DE (1) DE69633126T2 (fr)
DK (1) DK0832101T3 (fr)
ES (1) ES2227592T3 (fr)
WO (1) WO1996040739A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880097A (en) * 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
IL137164A0 (en) 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
MXPA02000762A (es) 1999-07-22 2002-08-20 Newbiotics Inc Metodos para tratar tumores resistentes a terapia.
US7172905B2 (en) * 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
AU2003247907A1 (en) * 2002-07-05 2004-01-23 University Of Chicago Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
TWI317738B (en) * 2005-01-06 2009-12-01 Telik Inc Tripeptide and tetrapeptide thioethers
JP5977229B2 (ja) * 2010-05-05 2016-08-24 プロリンクス リミテッド ライアビリティ カンパニー 巨大分子共役体からの徐放

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255789A (ja) * 1984-06-01 1985-12-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体,その製造法および抗腫瘍剤
JPH07119760B2 (ja) * 1984-07-24 1995-12-20 コモンウエルス・セ−ラム・ラボラトリ−ズ・コミッション ミモトープを検出または決定する方法
WO1986006487A1 (fr) * 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Methode de determination de mimotopes
HU201094B (en) * 1986-01-23 1990-09-28 Pfizer Process for producing immunostimulant acyltripeptides and pharmaceutical compositions comprising same as active ingredient
US5133866A (en) * 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US4963263A (en) * 1988-03-24 1990-10-16 Terrapin Technologies, Inc. Method of identity analyte-binding peptides
AU5435990A (en) * 1989-04-13 1990-11-05 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Monoclonal antibodies to human glutathione s transferase pi
JP2919867B2 (ja) * 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
ATE129019T1 (de) * 1990-05-07 1995-10-15 Dade Int Inc Verfahren und vorrichtung zur ausführung des zytotoxizitätsassays auf tumorzellen.
US5204241A (en) * 1990-10-22 1993-04-20 Oxi-Gene Inc. Glutathione-S-transferase mu as a measure of drug resistance
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
JPH06507549A (ja) * 1991-04-29 1994-09-01 テラピン テクノロジーズ,インコーポレイテッド 異常細胞のプロフィール作成および治療方法
US5545621A (en) * 1991-04-29 1996-08-13 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5556942A (en) * 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery

Also Published As

Publication number Publication date
JPH11507370A (ja) 1999-06-29
AU722595B2 (en) 2000-08-10
ATE273318T1 (de) 2004-08-15
DE69633126T2 (de) 2005-08-11
US5908919A (en) 1999-06-01
EP0832101B1 (fr) 2004-08-11
AU6108896A (en) 1996-12-30
CA2224191A1 (fr) 1996-12-19
EP0832101A2 (fr) 1998-04-01
DE69633126D1 (de) 2004-09-16
ES2227592T3 (es) 2005-04-01
WO1996040739A2 (fr) 1996-12-19
WO1996040739A3 (fr) 1997-01-30

Similar Documents

Publication Publication Date Title
DE69424298D1 (de) Durch glutathion-s-transferase aktivierte verbindungen
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
ES8707552A1 (es) Procedimiento de preparacion de nuevos derivados tetrapep- tidos de estructura policiclica nitrogenada,asi como sus sales de adicion a un acido o una base farmaceuticamente aceptables
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
ATE132150T1 (de) 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen
EP0938317A4 (fr) Compositions et procedes de reduction de la depression respiratoire
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
DK0832101T3 (da) Urethan-formidlede, GST-specifikke molekylfrigörelsessystemer
ES8801217A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
AU3367693A (en) Methotrexate derivative
DE69203724D1 (de) Amidderivate vom Antibiotikum A 40926.
HUP9801156A2 (hu) Karbapenem-3-karbonsav-észter-származékok
AU4765796A (en) Imidazolidinone derivatives as corrosion inhibitors
EP1020447A4 (fr) Composes a base de pyrazole et agent de lutte contre les maladies vegetales
RU94046387A (ru) Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
AU6117698A (en) Antiviral agents
AU5715894A (en) Methotrexate derivative
CA2211681A1 (fr) Nouveaux derives d'acide pyridonecarboxylique ou de ses sels et agent antibacterien contenant ces derives en tant qu'ingredient actif
TW333533B (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
AU740079C (en) Antirheumatic agents
EP1048649A4 (fr) Derives de 5-arylpyrrole
AU629713B2 (en) Pradimicin derivatives
CA2123890A1 (fr) Nouveau derive acide sulfonique et son utilisation en medecine
TW324719B (en) Succinamide compound, production thereof and use thereof